IP Library Granted Patent US 10,918,754
Granted Patent B2
US 10,918,754 · App. 16/498,080 · Granted Feb 16, 2021

Sterilisation method

Inventor: Philip Stephen Shodder (East Greenbush, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
A61L2/208A61L2/26A61L2202/122A61L2202/15A61L2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,918,754
App. No.
16/498,080
Granted
Feb 16, 2021
Kind
B2
Abstract

Embodiments of the present disclosure relate to systems and methods for the application of vaporized chemicals in the sterilization of medical products. For example, embodiments of the present disclosure may relate to systems and methods for the terminal sterilization of medical products using vaporized hydrogen peroxide (VHP). Embodiments of the present disclosure may relate to, e.g., systems and methods for the terminal sterilization of medical products, such as pre-filled syringes (PFS).

Claims (60)

1. A sterilization method comprising:

creating a turbulent flow within a chamber;

while maintaining the turbulent flow, performing a sterilization pulse comprising:

maintaining a sterilization pressure within the chamber of about 400 millibars to about 800 millibars for at least 5 minutes;

introducing vaporized hydrogen peroxide (VHP) into the chamber;

allowing the VHP to circulate within the chamber for at least 5 minutes; and

introducing a first gas into the chamber;

wherein, during the sterilization pulse, condensation forms on at least one surface within the chamber;

halting the turbulent flow within the chamber; and

performing an aeration pulse comprising:

introducing a second gas into the chamber;

maintaining a first aeration pressure in the chamber for at least 5 minutes;

increasing the pressure within the chamber to a second aeration pressure higher than the first aeration pressure; and

exhausting the second gas from the chamber;

wherein the first gas, the second gas, or both comprises nitrogen and/or air, and both the first gas and the second gas have a dew point of −10° C. or lower.

2. The method of claim 1 , wherein the second aeration pressure is about 550 millibars to about 1100 millibars.

3. The method of claim 1 , further comprising maintaining a chamber temperature of about 25° C. to about 60° C. during the sterilization pulse.

4. The method of claim 1 , wherein introducing VHP into the chamber comprises:

vaporizing an aqueous hydrogen peroxide solution, wherein the aqueous hydrogen peroxide solution has a concentration of about 10% to about 65%, of hydrogen peroxide by weight, based on the total weight of the aqueous hydrogen peroxide solution; or

introducing about 0.2 grams to about 3.0 grams of VHP per cubic foot of volume of the chamber into the chamber.

5. The method of claim 1 , wherein allowing the VHP to circulate within the chamber includes removing VHP from a lower interior of the chamber and re-introducing the removed VHP into an upper interior of the chamber.

6. The method of claim 1 , further comprising performing a drying pulse, wherein the drying pulse includes introducing nitrogen and/or air having a dew point of −10° C. into the chamber;

maintaining a first drying pressure in the chamber for at least 1 minute; and

maintaining a second drying pressure in the chamber for at least 1 minute,

wherein the second drying pressure is greater than the first drying pressure.

7. The method of claim 6 , wherein the first drying pressure and the second drying pressure are each about 500 millibars to about 850 millibars.

8. The method of claim 6 , wherein after the drying pulse, at least 99% by weight of the VHP introduced during the sterilization pulse is no longer in the chamber.

9. The method of claim 1 , further comprising, before the turbulent flow is created:

positioning a primary packaging component within the chamber, wherein the primary packaging component is configured for receiving a formulated drug substance including an antibody; and

preconditioning the chamber, wherein preconditioning the chamber comprises:

adjusting the temperature of the chamber to a temperature of about 25° C. to about 50° C.;

adjusting the pressure of the chamber to a pressure of about 400 millibars to about 700 millibars; and

maintaining the temperature of the chamber at about 25° C. to about 50° C. and maintaining the pressure of the chamber at about 400 millibars to about 700 millibars for at least 15 minutes.

10. A sterilization method comprising:

positioning a primary packaging component within a chamber, wherein the primary packaging component is configured for receiving a formulated drug substance including an antibody;

creating a turbulent flow within the chamber;

while maintaining the turbulent flow, performing a plurality of sterilization pulses, wherein each sterilization pulse includes:

maintaining a sterilization pressure within the chamber of about 400 millibars to about 800 millibars for at least 5 minutes;

introducing vaporized hydrogen peroxide (VHP) into the chamber;

allowing the VHP to circulate within the chamber for at least 5 minutes; and

introducing a first gas into the chamber;

performing a plurality of aeration pulses after performing the sterilization pulse, wherein each aeration pulse includes:

introducing a second gas into the chamber;

maintaining a first aeration pressure of about 400 millibars to about 800 millibars in the chamber for at least 5 minutes;

increasing the pressure within the chamber to a second aeration pressure of about 550 millibars to about 1100 millibars and greater than the first aeration pressure; and

exhausting the second gas from the chamber; and

performing a plurality of drying pulses after performing the plurality of aeration pulses, wherein each of the plurality of drying pulses includes:

introducing a third gas into the chamber;

maintaining a first drying pressure of about 500 millibars to about 850 millibars in the chamber for at least 1 minute; and

maintaining a second drying pressure higher than the first drying pressure in the chamber for at least 1 minute;

wherein the first gas, and one or more of the second gas and the third gas, has a dew point of −10° C. or lower,

wherein during a sterilization pulse of the plurality of sterilization pulses, a condensation layer forms on a surface of the primary packaging component.

11. The method of claim 10 , further comprising, after the primary packaging component is positioned within the chamber, and prior to creating a turbulent flow within the chamber, preconditioning the chamber, wherein preconditioning the chamber comprises:

adjusting the temperature of the chamber to a temperature of about 25° C. to about 50° C.;

adjusting the pressure of the chamber to a pressure of about 400 millibars to about 700 millibars; and

maintaining the temperature of the chamber at about 25° C. to about 50° C. and maintaining the pressure of the chamber at about 400 millibars to about 700 millibars for at least 15 minutes.

12. The method of claim 10 , wherein after the plurality of drying pulses, a concentration of VHP in the chamber is less than 1% of a concentration of VHP in the chamber prior to the plurality of aeration pulses.

13. The method of claim 10 , wherein a concentration of hydrogen peroxide in the condensation layer near the surface of the primary packaging component is greater than an average hydrogen peroxide concentration of the condensation layer.

14. The method of claim 1 , wherein the condensation comprises water and hydrogen peroxide.

15. The method of claim 14 , wherein the quantity of hydrogen peroxide is greater than the quantity of water.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2020
From: SHODDER, PHILIP STEPHEN
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 051536/0371 →
Continuity (3)
Provisional Application 62568850 · Oct 6, 2017
Provisional Application 62477030 · Mar 27, 2017
Related Publication 20200101186A1 · Apr 2, 2020
Cited By (3)
US 12,233,177 US 12,649,031 US 12,698,125